Idiopathic pulmonary fibrosis: A need for treatment with drugs other than corticosteroids - A role for antifibrotic agents?

Mayo Clinic Proceedings

Volumn 72, Issue 3, 1997, Pages 285-287

  Raghu, G ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; FIBRONECTIN; GAMMA INTERFERON; HYDROXYPROLINE; NICOTINIC ACID; PIRFENIDONE; TAURINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HUMAN; INFLAMMATION; LUNG FIBROSIS; LUNG PARENCHYMA;

EID: 0031432691     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.3.285     Document Type: Editorial

References (19)

1. DM Mannino RA Etzel RG Parrish Pulmonary fibrosis deaths in the United States, 1979-1991: an analysis of multiple-cause mortality data Am J Respir Crit Care Med 153 1996 1548 1552
2. M Turner-Warwick B Burrows A Johnson Cryptogenic fibrosing alveolitis: clinical features and their influence on survival Thorax 35 1980 171 180
3. CL Rochester JA Elias Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders Semin Respir Med 14 1993 389 416
4. G Raghu M Kinsella Cytokine effects on extracellular matrix Lung Biol Health Dis 61 1993 491 543
5. J Meier-Sydow SM Weiss R Buhl M Rust G Raghu Idio-pathic pulmonary fibrosis: current clinical concepts and challenges in management Semin Respir Crit Care Med 15 1994 77 96
6. M Turner-Warwick B Burrows A Johnson Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival Thorax 35 1980 593 599
7. T Izumi S Nagai Y Kondo M Tamura Ten-year follow up of 222 patients with idiopathic pulmonary fibrosis (IPF)-a nation-wide survey report in Japan [abstract] Am Rev Respir Dis 145 Suppl 1992 A218
8. G Raghu WJ Depaso K Cain SP Hammar CE Wetzel DF Dreis Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial Am Rev Respir Dis 144 1991 291 296
9. MA Johnson S Kwan NJ Snell AJ Nunn JH Darbyshire M Turner-Warwick Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis Thorax 44 1989 280 288
10. GW Hunninghake AR Kalica Approaches to the treatment of pulmonary fibrosis Am J Respir Crit Care Med 151 1995 915 918
11. G Raghu YY Chen V Rusch PS Rabinovitch Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs Am Rev Respir Dis 138 1988 703 708
12. SI Rennard PB Bitterman T Ozaki WN Rom RG Crystal Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro: the basis of a possible therapeutic approach to the fibrotic disorders Am Rev Respir Dis 137 1988 181 185
13. MF Gourley MF Seldin AD Steinberg Immunoregulatory agents JI Gallin IM Goldstein R Snyderman Inflammation: Basic Principles and Clinical Correlates 2nd ed. 1992 Raven Press New York 1103 1126
14. SG Peters JC McDougall WW Douglas DT Coles RA DeRemee Colchicine in the treatment of pulmonary fibrosis Chest 103 1993 101 104
15. KC Meyer G Raghu Perspectives and future advances on the diagnosis and treatment of idiopathic pulmonary fibrosis Lung Biol Health Dis 80 1995 837 874
16. AS Narayanan J Whitney A Souza G Raghu Effect of γ-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts Chest 101 1992 1326 1331
17. RJ Blaisdell SN Giri Mechanism of antifibrotic effect of taurine and niacin in the multidose bleomycin-hamster model of lung fibrosis: inhibition of lysyl oxidase and collagenase J Biochem Toxicol 10 1995 203 210
18. SN Iyer JS Wild MJ Schiedt DM Hyde SB Margolin SN Giri Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters J Lab Clin Med 125 1995 779 785
19. JM Lurton T Trejo AS Narayanan G Raghu Pirfenidone inhibits the stimulatory effects of pro-fibrotic cytokines on human lung fibroblasts in vitro Am J Respir Crit Care Med 153 1996 A403